MedTrace Logo

Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)

NCT04822142 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-03-01

No results posted yet for this study

Summary

To estimate the prevalence of congenital CMV infection in Vietnamese neonates and relating morbidity within 2-year follow-up. Along with evaluating the predictive value of the presence and the level of CMV replication in the first trimester in a highly seropositive population

Conditions

  • Prenatal Infection
  • Congenital Infection
  • Neonatal Disease

Sponsors & Collaborators

  • Hôpital Necker-Enfants Malades

    collaborator OTHER

  • Hanoi Obstetrics and Gynecology Hospital

    lead OTHER

Principal Investigators

  • Yves Ville, MD.PhD · Hôpital Necker-Enfants Malades

  • Marianne Leruez-Ville, MD.PhD · Hôpital Necker-Enfants Malades

  • Anh Nguyen Duy, MD.PhD · Hanoi Obstetrics and Gynecology Hospital

  • Ha Nguyen Thi Thu, MD.PhD · Hanoi Obstetrics and Gynecology Hospital

  • Linh Dinh Thuy, MD.PhD · Hanoi Obstetrics and Gynecology Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2025-11-30
Completion
2026-06-01

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04822142 on ClinicalTrials.gov